TEST
CODE
|
NAME
OF TEST
|
PREVIOUS
REFERENCE VALUES
|
ACTUAL
REFERENCE VALUES
|
163
|
17-BETA
ESTRADIOL, SERUM
|
Children: Less than 30 pg/mL
Male: Less than 55 pg/mL Female, Follicular phase: 30 - 200 pg/mL Ovulatory peak: 100 - 450 pg/mL Luteinic phase: 50 - 250 pg/mL Pregnant: 500 - 26600 pg/mL Menopause: Less than 55 pg/mL |
Follicular
phase: 20-150 pg/mL
Late follicular phase: 40-350 pg/mL Ovulatory peak: 150-750 pg/mL Luteinic phase: 30-450pg/mL Postmenopause: <21 pg/mL Men: 10-50 pg/mL Children (1-12 años):5-30 pg/mL Boys (12-17): 5-45 pg/mL Girls (12-17): 24-410 pg/mL |
106
|
ADRENOCORTICOTROPHIC
HORMONE (ACTH), PLASMA
|
Morning:
14 - 64 pg/mL
Evening: Less than 30 pg/mL |
Less
than 46 pg/mL
|
2119
|
ALBUMIN
, SERUM
|
Adults:
35-52 g/L
Neonates (0-4 days): 28-44 g/L * CALIBRATOR ATTRIBUTABLE TO REFERENCE STANDARD IFCC CRM 470. |
Adults: 35-52 g/L
|
476
|
ALKALINE
PHOSPHATASE, SERUM
|
Adults: 30-120 U/L
1-30 days :
Men 75-316
U/L - women 48-406 U/L
30 days-1 year:
Men 82-383
U/L - women 124-341 U/L
1-3 years :
Men 104-345 U/L - women 108-317 U/L
4-6 years :
Men 93-309
U/L - women 96-297 U/L
7-9 years :
Men 86-315
U/L - women 69-325 U/L
10-12 years :
Men 42-362
U/L - women 51-332 U/L
13-15 years :
Men 74-390
U/L - women 50-162 U/L
16-18 years :
Men 52-171 U/L - women 47-119 U/L
|
0-365 days:
Men: 76-383 U / L; Women: 48-406 U / L
1-10 years:
Men: 86-345 U / L; Women: 69-325 U / L
10-13 years:
Men: 42-362 U / L; Women: 51-332 U / L
13-15 years:
Men: 74-390 U / L; Women: 50-162 U / L
15-18 years:
Men: 52-171 U / L; Women: 47-119 U / L
Over 18 years:
Men: 30-120 U / L; Women: 30-120 U / L
|
109
|
ALPHA-L-FETOPROTEIN
(AFP)
|
Adults
: Less than 5.72 ng/mL
Pregnancy: 15 weeks : 14.2 - 38 ng/mL 16 Weeks : 13.6 - 52.8 ng/mL 17 Weeks : 13 - 72.3 ng/mL 18 Weeks : 8.3 - 74.3 ng/mL 19 Weeks : 23.3 -97.7 ng/mL 20 Weeks : 30.8 -93.8 ng/mL 21 Weeks : 15.5 -127 ng/mL *For the evaluation of Neuronal Tube Defect Risk, the limit must increased at least 1.5 the values indicated on the table. *For the evaluation of Neuronal Tube Defect Risk, the inferiors the inferiors limits indicated on the table of pregnancy must considered |
<
10 ng/ml
|
112
|
AMYLASE
TOTAL (ALPHA AMYLASE), URINE
|
Men: Less or equal tan 490 U/L
Women: Less or equal than 450 U/L |
Less
than 550 U/L
|
4268
|
BETA
2-MICROGLOBULIN, URINE
|
Less
than 370 µg/24 H
|
30-
370 µg/24 H
|
1926
|
BICARBONATE,
SERUM
|
Neonates
: 17 - 24 mmol/L
Infants : 19 - 24 mmol/L 2 months to 2 years: 16 - 24 mmol/L Adults : 21 - 31 mmol/L |
21
- 31 mEq/L
|
762
|
CA
125 (TUMOR MARKER), SERUM
|
Less
than 21 U/mL
|
Less
than 35 UI/mL
|
863
|
CA
19-9 (TUMOR MARKER), SERUM
|
Less
than 33 U/mL
|
Less
than 37 U/mL
|
304
|
CALCITONIN,
SERUM
|
Men: Less than 11.8 pg/mL
Women: Less than 4.8 pg/mL |
Men: Less than 8.4 pg/mL
Women: Less than 5 pg/mL |
302
|
CALCIUM
TOTAL, URINE
|
Normal diet (medium) : 100 - 200 mg/24H
Diet low in calcium : Less than 150 mg/24H Diet rich in calcium : 240 - 300 mg/24H |
100-240
mg/24h
|
301
|
CALCIUM,
SERUM
|
Children:
0-10 days : 7.6 - 10.4 mg/dL 10 days-24 months: 9 - 11.0 mg/dL 2-12 years : 8.8 - 10.8 mg/dL Adults : 8.8 - 10.6 mg/dL |
8.6-10.2
mg/dL
|
307
|
CARBAMAZEPINE,
SERUM
|
Therapeutic level: 4 - 12 µg/mL
Toxic levels: Greather than 15 µg/mL |
4-10 μg/ml
|
127
|
CARCINOEMBRYONIC
ANTIGEN - CEA, SERUM
|
Non smokers: 0 - 5
ng/mL
Smokers : Up to 10 ng/mL |
Less
than 5 ng/mL
|
2926
|
CHORIONIC GONADOTROPHINS (FREE BETA HCG), SERUM
|
Male : Less
than 0.3 ng/mL
Female: Not pregnant: Less than 0.3 ng/mL Pregnancy: Media 8 Weeks 87.49 ng/mL 9 Weeks 81.84 ng/mL 10 Weeks 67.17 ng/mL 11 Weeks 51.95 ng/mL 12 Weeks 40.49 ng/mL 13 Weeks 34.19 ng/mL 14 Weeks 23.52 ng/mL 15 Weeks 18.80 ng/mL 16 Weeks 18.33 ng/mL 17 Weeks 11.02 ng/mL 18 Weeks 09.19 ng/mL 19 Weeks 05.21 ng/mL |
Men and non pregnant women: <5 mUI/mL
Pregnant women: 4 weeks: 5-100 mUI/mL 5 weeks: 200-3.000 mUI/mL 6 weeks: 10.000-80.000 mUI/mL 7-14 weeks: 90.000-500.000 mUI/mL 15-26 weeks: 5.000-80.000 mUI/mL 27-40 weeks: 3.000-15.000 mUI/mL |
159
|
CORTISOL,
SERUM
|
Ext.morning (8H)
: 5 - 25 µg/dL
Ext.evening (18H) : 2 - 13 µg/dL |
Ext.morning (8H)
: 5 - 23 µg/dL
|
215
|
C-PEPTIDE,
SERUM
|
0.8-4
ng/ mL
|
1.1-4.4
ng/mL
|
324
|
CREATININE-
SERUM
|
0.6-1.4
mg/dL
|
Men 18-60 years: 0.9-1.3 mg / dL
Women 18-60 years: 0.6-1.1 mg / dL Men older than 60 years: 0.8-1.3 mg / dL Women older than 60 years: 0.6-1.2 mg / dL Children: 0.3-0.7 mg / dL Adolescents: 0.5-1 mg / dL |
325
|
CREATININE,
URINE
|
Male : 1500 - 2500 mg/24H
Female: 800 - 1500 mg/24H |
Male : 1000 - 2000 mg/24H
Female: 800 - 1800 mg/24H |
161,
4563, 4564, 4565, 4566, 4567, 4568 4569, 4570, 4571
|
DEHYDROEPIANDROSTENEDIONE
SULFATE (DHEAS), SERUM
|
MEN: 0.8 -
5.6 µg/mL
WOMEN: 0.35 - 4.3 µg/mL |
Men: 2.17-15.2 µmol/L
Womens: 0.92-11.67 µmol/L |
162
|
DIGOXIN,
SERUM
|
THERAPEUTIC LEVEL: 0.8 - 2.2 ng/mL
TOXIC LEVEL : Greater than 2.4 ng/mL |
0.8 - 2.0 ng/mL
|
4343
|
FACTOR XA (ANTI ACTIVATED), PLASMA
|
0,5-1,2
UI/mL
|
0.5-1.0
U/mL
|
167
|
FERRITIN,
SERUM
|
Men: 20-250 ng/mL
Women: 10-120 ng/mL Men : 20-250 ng/mL Women : 10-120 ng/mL Children: Up to 1 month : 6-400 ng/mL From 1 to 6 months : 6-410 ng/mL From 6-12 months : 6-80 ng/mL From 1 to 5 years : 6-60 ng/mL From 6 to 19 years : 6-320 ng/mL * Calibrator attributable to the 3rd International Standard of ferritin, biotechnology code NIBSC (National Institute for Biological Standards and Control): 94/572. |
Men: 20-250 ng/mL
Women: 10-120 ng/mL |
168
|
FIBRINOGEN,
PLASMA
|
180-240
mg/dL
|
200-400
mg/L
|
169
|
FOLLICLE
HORMONE (FSH), SERUM
|
MEN: 0.7 - 11.1 mUI/mL
WOMEN: Follicular phase: 2.8 - 11.3 mUI/mL Follicular phase days 2 and 3: 3.0 - 14 mUI/mL Average cycle: 5.8 - 21 mUI/mL Luteinic phase : 1.2 - 9.0 mUI/mL Postmenopausicas: 21.7 - 153 mUI/mL Oral contraceptive: Less than 4.9 mUI/mL PEDIATRIC: BOYS: Cordon: Less than 1.2 mUI/mL |
Follicular phase: 1.4-9.9 UI/L
Ovulatroy peak: 0.2-17.2 UI/L Luteinic phase: 1.9-9.2 UI/L Postmenopause: 19.3-100.6 UI/L Men: 1.4-15.4 UI/L |
358
|
HAEMOGLOBIN
A1C, WHOLE BLOOD
|
4.7
- 6.4 %
28 - 46 mmol/mol |
Less than 48 mmol/mol
Prediabetes: 39 - 46 mmol/mol |
117
|
HEPATITIS B IGM CORE ANTIBODIES, SERUM
|
Not
detected
|
Not detected: Less than 0.8
Undetermined: 0.8-1.0 Positive: Greater than 1.0 |
786
|
HEPATITIS B SURFACE ANTIBODY (HBS-AB), SERUM
|
Active immunization: Greater than 10 mIU/mL
|
Negative: Less than 10 mIU/mL.L
Active immunization: Greater or equal than 10 mIU/mL |
2140
|
HOMOCYSTEINE
, PLASMA
|
Normal : < 15.0 µmol/L
Risk Vascular Disease : > 15.0 µmol/L Vitamin Deficiency : 15.0 - 30 µmol/L After Methionine, Heterozygote: 30 - 100 µmol/L Homozygote : > 100 µmol/L |
Younger than 15 years: Less than 10 μmol / L
15-65 years: Less than 15 μmol / L Older than 65 years: Less than 20 μmol / L |
193
|
IMMUNOGLOBULIN
- E (IGE) , SERUM
|
Newborns :
0 - 1.5 IU/mL
1 year : 0 - 15 IU/mL 1 - 5 years : 0 - 60 IU/mL 6 - 9 years : 0 - 90 IU/mL 10 -15 years: 0 - 200 IU/mL Adults : 0 - 100 IU/mL * CALIBRATION WITH REFERENCE STANDARD IRP 75/502 |
Adults: Lees than 160 UI/mL
|
194
|
IMMUNOGLOBULIN
- G (IGG) , SERUM
|
Newborns
: 660-1750 mg/dL
1- 3 Months : 200-1050 mg/dL 3- 6 Months : 220-690 mg/dL 6-12 Months : 260-950 mg/dL 1-4 years : 360-1340 mg/dL 4-8 years : 540-1500 mg/dL 8-12 years : 630-1550 mg/dL 12-16 years : 670-1560 mg/dL 16-18 years : 720-1550 mg/dL Adults : 700-1600 mg/dL *Proteins in Clinical and Laboratory Medicine, Lothar Thomas MD, English Edition 2008 (Siemens). * CALIBRATOR ATTRIBUTABLE TO REFERENCE STANDARD IFCC CRM 470. |
0-1 years: 313-1170
mg/dL
2-4 years: 295-1156 mg/dL 5 - 10 years: 386-1682 mg/dL 11-16 years: 503-1719 mg/dL 17-18 years : 487-1327 mg/dL >18 years: 767-1590 mg/dL |
195
|
IMMUNOGLOBULIN
- M (IGM) , SERUM
|
Newborns
: 6 - 21 mg/dL
3-6 months : 17-100 mg/dL 6-9 months : 26-130 mg/dL 9-12 months : males 33-140 mg/dL - female 33-150 mg/dL 1-2 years : males 37-160 mg/dL - female 40-180 mg/dL 2-4 years : males 41-160 mg/dL - female 47-190 mg/dL 4-8 years : males 43-180 mg/dL - female 52-220 mg/dL 8-12 years : males 47-180 mg/dL - female 60-240 mg/dL 12-16 years : males 49-190 mg/dL - female 65-260 mg/dL 16-18 years : males 50-190 mg/dL - female 68-260 mg/dL Adults : males 40-230 mg/dL - female 40-280 mg/dL *Proteins in Clinical and Laboratory Medicine, Lothar Thomas MD, English Edition 2008 (Siemens). * CALIBRATOR ATTRIBUTABLE TO REFERENCE STANDARD IFCC CRM 470. |
0-1 years: 46-152
mg/dL
2-4 years: 37-184 mg/dL 5 - 10 years: 37-251 mg/dL 11-16 years: 41-244 mg/dL 17-18 years : 49-201 mg/dL >18 years: 37-286 mg/dL |
190
|
IMMUNOGLOBULIN
-A (IGA) , SERUM
|
Newborns
: 1-6 mg/dL
3-6 months : 10-60 mg/dL 6-9 months : 8-80 mg/dL 9-12 months : 11-90 mg/dL 1-2 years : 14-150 mg/dL 2-4 years : 21-190 mg/dL 4-8 years : 30-250 mg/dL 8-12 years : 46-290 mg/dL 12-16 years : 58-310 mg/dL 16-18 years : 67-320 mg/dL *Adults : 70-400 mg/dL Proteins in Clinical and Laboratory Medicine, Lothar Thomas MD, English Edition 2008 (Siemens). |
0-1 years: 36-79
mg/dL
2-4 years: 27-246 mg/dL 5 a 10 años: 34-274 mg/dL 11-16 years: 52-319 mg/dL 17-18 years : 60-337 mg/dL >18 years: 61-356 mg/dL |
196
|
IMMUNOGLOBULINS G,A,M , SERUM
|
IgG(mg/dL) IgA(mg/dL) IgM(mg/dL)
Newborns : 600-1350 7- 22 4- 70 1- 3 Months : 290- 870 10- 40 20- 90 3- 6 Months : 230- 450 10- 65 30-100 6-12 Months : 230- 650 20- 90 30-140 1- 3 years : 330- 900 20-130 45-155 3- 5 years : 480-1030 35-145 50-155 5- 9 years : 540-1160 40-160 50-160 9-12 years : 620-1230 45-175 50-165 12-15 years : 650-1240 50-205 40-165 Adults: : 700-1600 70-400 40-230 * CALIBRATION WITH REFERENCE STANDARD IFCC/BCR/CAP-CRM 470 |
IgG:
0-1 years: 313-1170 mg/dL 2-4 years: 295-1156 mg/dL 5 - 10 years: 386-1682 mg/dL 11-16 years: 503-1719 mg/dL 17-18 years : 487-1327 mg/dL >18 years: 767-1590 mg/dL IgA: 0-1 years: 36-79 mg/dL 2-4 years: 27-246 mg/dL 5 a 10 años: 34-274 mg/dL 11-16 years: 52-319 mg/dL 17-18 years : 60-337 mg/dL >18 years: 61-356 mg/dL IgM: 0-1 years: 46-152 mg/dL 2-4 years: 37-184 mg/dL 5 - 10 years: 37-251 mg/dL 11-16 years: 41-244 mg/dL 17-18 years : 49-201 mg/dL >18 years: 37-286 mg/dL |
197
|
INSULIN,
SERUM
|
5-25
μU/ml
|
2-25
μU/ml
|
186
|
IRON,
SERUM
|
Neonates : 100 - 250 µg/dL
Babies : 40 - 100 µg/dL Children : 50 - 120 µg/dL Man : 70 - 180 µg/dL Woman : 60 - 180 µg/dL |
60-150
µg/dL
|
371
|
LACTATE
DEHYDROGENASE (LDH), SERUM
|
230-
460 U/L (37ºC)
|
208-378
U/L
|
202
|
LIPASE,
SERUM
|
Children under 1 year: <8 U / L
From 1-9 years : 5-31 U / L From 10 to 18 years : 7-35 U / L Adults : <67 U / L |
Less
than 67 U/L
|
199
|
LUTEINIZING
HORMONE (LH), SERUM
|
MEN: 0.8 - 7.6 mUI/mL
WOMEN: Follicular phase: 1.1 - 11.6 mUI/mL Average cycle: 17 - 77 mUI/mL Luteinic phase: Less than 14.7 mUI/mL Perimenstrual: Less than 12.0 mUI/mL Postmenopausicas: 11.3 -39.8 mUI/mL Oral contraceptive: Less than 8.0 mUI/mL PEDIATRIC: BOYS: Cordon: Less than 3.6 mUI/mL Less than 1.5 years: Less than 4.1 mUI/mL 1.6-9 years: Less than 3.8 mUI/mL GIRLS: Cordon: Less than 0.1 mUI/mL Less than 1.5 years: Less than 2.3 mUI/mL 1.6 - 9 years: Less than 1.3 mUI/mL |
Follicular
phase: 1.7-15 UI/L
Ovulatory peak: 21.9-56.6 UI/L Luteinic phase: 0.6-16.3 UI/L Postmenopause: 14.2-52.3 UI/L Men: 1.2-7.8 UI/L |
207
|
MAGNESIUM,
URINE
|
60-75
mg/24 h
|
73-122
mg/24 h
|
872
|
MICROALBUMINE,
URINE
|
Isolated urine
: Up to 3 mg/dL
Urine 24 hours : Up to 16 µg/minuto * CALIBRATION WITH REFERENCE STANDARD IFCC/BCR/CAP-CRM 470 |
Less
than 30 mg/24 h
|
387
|
MYOGLOBIN,
SERUM
|
Until
70 ng/mL
|
inferior
a 36.4 ng/mL
|
1019
|
PARATHYRID HORMONE INTACT (PTH), SERUM
|
10-73
pg/mL
|
10-65
pg/mL
|
439
|
PHOSPHORUS,
URINE
|
0,3-1,0
g/24h
|
400-1300
mg/24h
|
2780
|
PLASMINOGEN
ACTIVITY, PLASMA
|
70-140%
|
75-140%
|
219
|
POTASSIUM,
SERUM
|
3.6
- 5.5 mEq/L
|
3.5
- 5.1 mmol/L
|
222
|
PROGESTERONE,
SERUM
|
Children:
< 1 year: 0.1 -
17 ng/mL
1 - 9 years: 0.1 - 1.3 ng/mL Female: Follicular phase: 0.1 - 1.5 ng/mL Luteinic phase: 2.5 -28.1 ng/mL Menopause: 0.1 - 1.0 ng/mL Oral Anticonceptivs: 0.3 - 0.9 ng/mL Pregnant 1er Trimonthter: 9.3 - 33.2 ng/mL 2nd Trimonthter: 29.5 -50.0 ng/mL 3rd Trimonthter : 83.1 - 160 ng/mL Male: 0.27 -0.90 ng/mL |
Normal women:
Follicular phase:<0.89 µg/L Ovulatory peak <12 µg/L Luteinic phase: 1.84-24 µg/L Prepubertal children: <0.35 µg/L Postmenopause: <0.2 µg/L Men: <0.2 µg/L |
223, 4644, 4645,4646, 4647, 4648, 4649,
4650, 4651, 4652
|
PROLACTIN,
SERUM
|
MEN: 2.5- 17
ng/ml
WOMEN: 1.9- 25 ng/ml PEDIATRIC: Cordon: 160-665 ng/ml Less than 0.5 years: 2-125 ng/ml 0.6-9 years: 1-40 ng/ml |
Men : 3.0
- 14.7 µg/L
Women : 3.8 - 23 µg/L |
850
|
PROTEIN
TOTAL , SERUM
|
66
- 83 g/L
|
64
- 83 g/L
|
319
|
PROTEIN
TOTAL , URINE
|
Spot urine : Less than 10 mg/dL
Urine 24 H : 10 - 150 mg/24H |
Less
than 150 mg/24 h
|
407
|
PSA
(PROSTATE SPECIFIC ANTIGEN), SERUM
|
Less
than 3 ng/mL
|
Less
than 4 ng/mL
|
230
|
RUBELLA
IGG ANTIBODIES, SERUM
|
NEGATIVE
: Less than 5.0 IU/mL
GREY ZONE : 5.0 - 10 IU/mL POSITIVE : Greater than 10.0 IU/mL * In absence of positive IgM, the 3 levels of positivity of IgG are indicators of active immunity. * To descard active infection is recommended to do Rubella-IgM. Or seroconversion for IgG Rubella antibody after 2-3 weeks of first sample. Increasing of the index 2 or more times indicates active infection. |
Non-immune: Less than 5.0 IU / mL
Undetermined: 5.0 - 9.99 IU / mL Immunity weak: 10 - 15 IU / mL Immune: Greater than 15 IU / mL |
547
|
SEX HORMONE BINDING GLOBULIN (SHBG), SERUM
|
Childs : 40 -
90 nmol/L
Male : 10 - 50 nmol/L Female : 25 - 90 nmol/L Pregnant: 250 -500 nmol/L |
Men: 10-57 nmol/L
Women: 18-144 nmol/L |
235
|
SODIUM,
SERUM
|
133
- 155 mEq/L
|
136
- 146 mmol/L
|
236
|
SODIUM,
URINE
|
30-260
mEq/24h
|
40-220
mmol/24h
|
711
|
T3
FREE, SERUM
|
1.8-4.2
pg/mL
|
2.1-4.4
ng/L
|
238
|
T3
TOTAL (TRIIODOTHYRONINE), SERUM
|
60-181
ng/dL
|
Children 1-20 years: 0.8-2.1 µg/L
Adults 21-50 years: 0.7-2 µg/L Adults 51-90 years: 0.4-1.8 µg/L |
240
|
T4-
FREE, SERUM
|
NORMAL VALUES
: 0.89 - 1.76 ng/dL
HYPOTHYROIDISM : Less than 0.89 HYPERTHYROIDISM: Greather than 1.76 |
Children (1-20
years): 0.8-2 ng/dL
Adults: 0.8-2.7 ng/dL |
239
|
T4
TOTAL (THYROXINE), SERUM
|
4.5
- 12.5 µg/dL
|
Children (1-15 years): 5.6-11.7 µg/dL
Men: 4.6-10.5 µg/dL Women: 5.5-11µg/dL |
244
|
TESTOSTERONE,
SERUM
|
Males:
* 20-49 years : 72 - 853 ng/dL * Greater than 50 years : 129 - 767 ng/dL Females: * Ovulatory phase : < 73 ng/dL * Postmenopausal : < 43 ng/dL |
Males:
1 - 9 years: <0.3 ng/mL Adults: 2.6 - 10 ng/mL Females: 1- 9 years: <0.2 ng/mL Adults: 0.15- 0.7 ng/mL |
412
|
THYROGLOBULIN,
SERUM
|
Less
than 55 ng/mL
|
3-42
ng/mL
|
248
|
TRANSFERRIN,
SERUM
|
Adults and children over 10 years: 200-360 mg/dL
Children: 0-4 Days: 130-275 mg/dL 3 months - 10 years: 203-360 mg/dL * Calibrator traceable to Standard ERM® DA470 |
200
– 360 mg/dL
|
249
|
TSH (THYROID STIMULATING HORMONE), SERUM
|
0.3
- 5 µU/mL
Límite de sensibilidad: 0.01 µU/mL * CALIBRACION CON ESTANDAR DE REFERENCIA WHO 2nd IRP 80/558 |
Children 1-20 years: 0.7-6.4 mU/L
Adults 21-54 years: 0.4-4.2 mU/L Adults 55-87 years: 0.5-8.9 mU/L Reference values in pregnant women: - 1st trimester: up to 2.5 mU/L - 2nd and 3rd trimester: up to 3.5 mU/L |
2005
|
UREA
, SERUM
|
17
- 50 mg/dL
|
17
- 49 mg/dL
|
884
|
UREA,
URINE
|
14-35
g/24h
|
13-36
g/24h
|
254
|
VITAMIN
B12 (CYANOCOBALAMINE), SERUM
|
180-914
pg/mL
|
206 - 678 pg/mL
|
Monday, January 9, 2017
REFERENCE VALUES MODIFICATION
We inform you as of tomorrow 9th January 2017, the reference values of the following tests have been modified.
Labels:
Reference values
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment